Assessment of selected media supplements to improve F/HN lentiviral vector production yields. (2017)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-07893-3
PubMed Identifier: 28860488
Publication URI: http://europepmc.org/abstract/MED/28860488
Type: Journal Article/Review
Volume: 7
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322